AFAXYS, INC.
CHARLESTON, SC

Afaxys, Inc. was founded as a first-of-its-kind healthcare company in 2008 to ensure that the public health sector had reliable access to affordable, quality, FDA-approved products and services they need to care for their patients. Afaxys, Inc. is a mission-driven, socially conscious business enterprise dedicated to serving the women's healthcare needs of public health providers and their patients. Afaxys, Inc. is comprised of two business divisions: Afaxys Pharma and Afaxys Group Services. Afaxys Pharma brings a strong portfolio of branded and generic oral contraceptives to the public health market. We are dedicated to offering a sustainable supply of quality, affordable women's healthcare products and services for the public health sector. To learn more about the products Afaxys Pharma offers, click below. view products Afaxys Group Services negotiates favorable pricing across a broad base of healthcare products and services so its members have access to best-in-class suppliers and service providers. Our strategic sourcing business model enables Afaxys to secure and provide consistent and reliable access to quality products and services at an affordable price. Afaxys' mission is to deliver products and services to public health providers affordably, reliably and with an unwavering focus on customer service and stakeholder needs. Afaxys is an emerging leader in the public health sector focused on women by: the need for healthcare products and services for millions of women dependent on the public health sector. a full range of quality, FDA-approved products for women that provide the optimal blend of availability and affordability for the people who need them most. a reliable supply of quality FDA-approved products at affordable prices to the public health sector. 7 brown non-hormone containing tablets of ferrous fumarate to help ease administration Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. Hypersensitivity to any component of this product 4. CARCINOMA OF THE BREAST AND REPRODUCTIVE ORGANS